EYEN Old Executives
| EYENDelisted Stock | USD 14.36 1.94 11.90% |
EYEN Old employs about 13 people. The company is managed by 9 executives with a total tenure of roughly 31 years, averaging almost 3.0 years of service per executive, having 1.44 employees per reported executive. Analysis of EYEN Old's management performance can provide insight into the firm performance.
EYEN |
EYEN Old Management Team Effectiveness
The company has return on total asset (ROA) of (1.1774) % which means that it has lost $1.1774 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.8803) %, meaning that it created substantial loss on money invested by shareholders. EYEN Old's management efficiency ratios could be used to measure how well EYEN Old manages its routine affairs as well as how well it operates its assets and liabilities.The market capitalization of EYEN Old is $80.75 Million. Roughly 86.19 percent of EYEN Old outstanding shares are held by general public with 0.42 (percent) owned by insiders and only 13.39 % by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Some institutional investors establish a significant position in stocks such as EYEN Old in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of EYEN Old, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
EYEN Old Workforce Comparison
EYEN Old is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 613. EYEN Old holds roughly 13.0 in number of employees claiming about 2.12% of equities under Health Care industry.
EYEN Old Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EYEN Old insiders, such as employees or executives, is commonly permitted as long as it does not rely on EYEN Old's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, EYEN Old insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mather Charles E Iv over six months ago Acquisition by Mather Charles E Iv of 61481 shares of Eyenovia subject to Rule 16b-3 | ||
Palanki Ram over six months ago Acquisition by Palanki Ram of 3000 shares of Eyenovia subject to Rule 16b-3 | ||
Geltzeiler Michael S over six months ago Acquisition by Geltzeiler Michael S of 5000 shares of Eyenovia subject to Rule 16b-3 | ||
Michael Rowe over six months ago Acquisition by Michael Rowe of 4890 shares of Eyenovia at 1.36 subject to Rule 16b-3 | ||
Jacobson Rachel over six months ago Acquisition by Jacobson Rachel of 24691 shares of Eyenovia at 2.32 subject to Rule 16b-3 | ||
Michael Rowe over six months ago Acquisition by Michael Rowe of 27071 shares of Eyenovia at 0.52 subject to Rule 16b-3 | ||
Michael Rowe over a year ago Acquisition by Michael Rowe of 4890 shares of Eyenovia at 1.36 subject to Rule 16b-3 | ||
Mather Charles E Iv over a year ago Acquisition by Mather Charles E Iv of 3000 shares of Eyenovia at 2.4899 subject to Rule 16b-3 |
EYEN Old Notable Stakeholders
An EYEN Old stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as EYEN Old often face trade-offs trying to please all of them. EYEN Old's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting EYEN Old's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Rowe | President CEO | Profile | |
| John CPA | CFO Secretary | Profile | |
| Andrew Jones | Chief Officer | Profile | |
| Bren Kern | VP Operations | Profile | |
| Enrico Brambilla | Senior RD | Profile | |
| Tony Cardinale | Vice Sales | Profile | |
| Norbert Lowe | Senior Operations | Profile | |
| Alexander Lobo | Investor Contact | Profile | |
| MD MPH | President, CoFounder | Profile |
About EYEN Old Management Performance
The success or failure of an entity such as EYEN Old often depends on how effective the management is. EYEN Old management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of EYEN management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the EYEN management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York. Eyenovia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.
EYEN Old Workforce Analysis
Traditionally, organizations such as EYEN Old use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare EYEN Old within its industry.EYEN Old Manpower Efficiency
Return on EYEN Old Manpower
| Revenue Per Employee | 4.4K | |
| Revenue Per Executive | 6.4K | |
| Net Loss Per Employee | 3.8M | |
| Net Loss Per Executive | 5.5M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in EYEN Stock
If you are still planning to invest in EYEN Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EYEN Old's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |